ABBOTT LABORATORIES — Director's Dealing 2020

Jul 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-07-21

Reporting Person: Wellisch Alejandro D (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-21	Common shares without par value	A	1497	—	Acquired	22167	Direct
2020-07-21	Common shares without par value	F	524	$99.08	Disposed	21643	Direct

Footnotes

F1: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3.